Prediction of metastases in melanoma patients with positive sentinel node: Histological and molecular approach

Journal of Dermatology

Volumn 34, Issue 1, 2007, Pages 31-36

  Tsutsumida, Arata ^a   Furukawa, Hiroshi ^a   Hata, Shinya ^a   Saito, Akira ^a   Yamamoto, Yuhei ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Melanoma; Micrometastasis; Quantitative polymerase chain reaction; Recurrence; Sentinel lymph nodes

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOMA; MELANOMA CELL; MICROMETASTASIS; MOLECULAR BIOLOGY; PREDICTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33845809536     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00212.x     Document Type: Article

References (13)

1. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
2. Takahashi Y, Hamada J, Murakawa K et al. Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 2004; 293: 144-153.
3. Thompson JF, McCarthy WH, Bosch CM et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-260.
4. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17: 976-983.
5. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998; 351: 793-796.
6. Cochran AJ. Prediction of outcome for patients with cutaneous melanoma. Pigment Cell Res 1997; 10: 162-167.
7. Scolyer RA, Li LX, McCarthy SW et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004; 122: 532-539.
8. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11: 162S-168S.
9. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004; 22: 3677-3684.
10. Shivers SC, Wang X, Li W et al. Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 1998; 280: 1410-1415.
11. Blaheta H-J, Ellwanger U, Schittek B et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000; 114: 637-642.
12. Giese T, Engstner M, Mansmann U, Hartschuh W, Arden B. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. J Invest Dermatol 2005; 124: 633-637.
13. Takeuchi H, Morton DL, Kuo C et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 2004; 22: 2671-2680.